Clinical Trial: Home High-Flow Nasal Cannula Vs. Noninvasive Ventilation for Stable Chronic Respiratory Failure

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06872801) titled 'Home High-Flow Nasal Cannula Vs. Noninvasive Ventilation for Stable Chronic Respiratory Failure' on Feb. 26.

Brief Summary: The goal of this clinical trial is to compare the effects of home high-flow nasal cannula (HFNC) therapy and noninvasive ventilation (NIV) in patients with stable chronic hypercapnic respiratory failure. The main questions it aims to answer are:

* Does HFNC or NIV reduce blood carbon dioxide levels more effectively?

* How well do patients tolerate and adhere to each therapy?

* Are there differences in oxygen saturation, respiratory rate, and quality of life between the two treatments?

Participants Will:

*...